1. An audit on the use of steroids in the management of odontogenic infections. Issue 10 (December 2020) Authors: Nassehi, Yalda; Wall, Lucy; Kaila, Harveen; Alakus, Conor; Williams, Luke; Messiha, Ashraf Journal: British journal of oral and maxillofacial surgery Issue: Volume 58:Issue 10(2020) Page Start: e146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study. Issue 3 (7th January 2016) Authors: Caplin, Martyn E; Pavel, Marianne; Ćwikła, Jarosław B; Phan, Alexandria T; Raderer, Markus; Sedláčková, Eva; Cadiot, Guillaume; Wolin, Edward M; Capdevila, Jaume; Wall, Lucy; Rindi, Guido; Langley, Alison; Martinez, Séverine; Gomez-Panzani, Edda; Ruszniewski, Philippe Journal: Endocrine-related cancer Issue: Volume 23:Issue 3(2016) Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Issue 5 (May 2019) Authors: Primrose, John N; Fox, Richard P; Palmer, Daniel H; Malik, Hassan Z; Prasad, Raj; Mirza, Darius; Anthony, Alan; Corrie, Pippa; Falk, Stephen; Finch-Jones, Meg; Wasan, Harpreet; Ross, Paul; Wall, Lucy; Wadsley, Jonathan; Evans, Jeff T R; Stocken, Deborah; Praseedom, Raaj; Ma, Yuk Ting; Davidson, B... Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study. Issue 18 (20th June 2022) Authors: Bridgewater, John; Fletcher, Peter; Palmer, Daniel H.; Malik, Hassan Z.; Prasad, Raj; Mirza, Darius; Anthony, Alan; Corrie, Pippa; Falk, Stephen; Finch-Jones, Meg; Wasan, Harpreet; Ross, Paul; Wall, Lucy; Wadsley, Jonathan; Evans, Thomas R.; Stocken, Deborah; Stubbs, Clive; Praseedom, Raaj; Ma, Y... Journal: Journal of clinical oncology Issue: Volume 40:Issue 18(2022) Page Start: 2048 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a series. (1st March 2022) Authors: Stewart, Kirsten E; Strachan, Mark WJ; Srinivasan, Devraj; MacNeill, Morna; Wall, Lucy; Nixon, Iain J Journal: British journal of surgery Issue: Volume 109(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a single-centre case series. Issue 2 (February 2023) Authors: Yeo, Justin; Stewart, Kirsten; Maniam, Pavithran; Strachan, Mark; Wall, Lucy; Srinivasan, Devraj; MacNeill, Morna; Nixon, Iain Journal: European journal of surgical oncology Issue: Volume 49:Issue 2(2023) Page Start: e30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC). Issue 2 (5th February 2020) Authors: Craig, Zoe; Swain, Jayne; Batman, Emma; Wadsley, Jonathan; Reed, Nicholas; Faluyi, Olusola; Cave, Judith; Sharma, Rohini; Chau, Ian; Wall, Lucy; Lamarca, Angela; Hubner, R; Mansoor, Wasat; Sarker, Debashis; Meyer, Tim; Cairns, David A; Howard, Helen; Valle, Juan W; McNamara, Mairéad G Journal: BMJ open Issue: Volume 10:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patients unfit for neoadjuvant therapy may still undergo resection of locally advanced esophageal or esophagogastric junctional cancer with acceptable oncological results. Issue 2 (February 2017) Authors: O'Neill, J. Robert; Kennedy, Ewan D.; Save, Vicki; Langdale-Brown, Barbara; Wall, Lucy; Skipworth, Richard J.E.; Paterson-Brown, Simon Journal: International journal of surgery Issue: Volume 2:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors. Issue 3 (March 2020) Authors: Grenader, Tal; Pavel, Marianne E.; Ruszniewski, Philippe B.; Ćwikła, Jarosław B.; Phan, Alexandria T.; Raderer, Markus; Sedláčková, Eva; Cadiot, Guillaume; Wolin, Edward M.; Capdevila, Jaume; Wall, Lucy; Rindi, Guido; Truong Thanh, Xuan-Mai; Caplin, Martyn E. Journal: Anti-cancer drugs Issue: Volume 31:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. QOL-12. "I'M JUST LIKE A BASKET FULL OF PROBLEMS": QUALITATIVE STUDY OF COGNITIVE DYSFUNCTION AND QUALITY OF LIFE IN GLIOMA SURVIVORS. (14th November 2022) Authors: Van Dyk, Kathleen; Wall, Lucy; Ellingson, Benjamin; An, Nicholas; Lai, Albert; Cloughesy, Timothy; Brauer, Eden R; Nghiemphu, Phioanh L Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗